NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE |
SCHEDULE
OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
| |
|
For the years ended December 31, |
|
| |
|
2021 |
|
|
2020 |
|
| Restricted stock |
|
|
2,431,515 |
|
|
|
2,952,499 |
|
| Stock options |
|
|
7,934,851 |
|
|
|
5,685,539 |
|
| Stock purchase warrants |
|
|
44,700,000 |
|
|
|
- |
|
| Total |
|
|
55,066,366 |
|
|
|
8,638,038 |
|
|
| SCHEDULE OF STOCK BASED COMPENSATION |
The
following table summarizes stock option-based option compensation for 2021 and 2020, which was allocated as follows:
SCHEDULE OF STOCK BASED COMPENSATION
| |
|
For the years ended December 31, |
|
| |
|
2021 |
|
|
2020 |
|
| Research and development |
|
$ |
1,915,000 |
|
|
$ |
3,126,000 |
|
| General and administrative |
|
|
3,335,000 |
|
|
|
2,727,000 |
|
| Stock option-based compensation expense included in operating expense |
|
|
5,250,000 |
|
|
|
5,853,000 |
|
| |
|
|
|
|
|
|
|
|
| Total stock option-based compensation expense |
|
|
5,250,000 |
|
|
|
5,853,000 |
|
| Tax benefit |
|
|
- |
|
|
|
- |
|
| Stock option-based compensation expense, net of tax |
|
$ |
5,250,000 |
|
|
$ |
5,853,000 |
|
|
| Restricted Stock [Member] |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| SCHEDULE OF STOCK BASED COMPENSATION |
The
following table summarizes restricted stock-based compensation for 2021 and 2020, which was allocated as follows:
SCHEDULE OF STOCK BASED COMPENSATION
| |
|
For the years ended December 31, |
|
| |
|
2021 |
|
|
2020 |
|
| Research and development |
|
$ |
1,384,000 |
|
|
$ |
957,000 |
|
| General and administrative |
|
|
2,282,000 |
|
|
|
1,377,000 |
|
| Restricted stock-based compensation expense included in operating expense |
|
|
3,666,000 |
|
|
|
2,334,000 |
|
| |
|
|
|
|
|
|
|
|
| Total restricted stock-based compensation expense |
|
|
3,666,000 |
|
|
|
2,334,000 |
|
| Tax benefit |
|
|
- |
|
|
|
- |
|
| Restricted stock-based compensation expense, net of tax |
|
$ |
3,666,000 |
|
|
$ |
2,334,000 |
|
|